New medicines used to treat type 2 diabetes and obesity have become very popular in recent years.
Drugs such as semaglutide and tirzepatide are widely prescribed because they can help people lose a significant amount of weight. For many patients, these medications have been life-changing, improving blood sugar control and lowering the risk of serious diseases.
However, a new study from the UNC School of Medicine suggests there may be an important downside that needs more attention. The research, published in the journal Annals of Internal Medicine, found that people taking these medications may lose a large amount of muscle along with fat during weight loss.
To understand why this matters, it helps to know that not all weight loss is the same. The human body is made up of fat, muscle, bones, and water. When people lose weight in a healthy way, the goal is usually to reduce fat while keeping as much muscle as possible. Muscle is important because it supports movement, balance, strength, and overall health.
Losing too much muscle can lead to weakness and reduced mobility. In older adults, this can increase the risk of falls and injuries. It can also affect independence and quality of life.
In this study, researchers reviewed data from multiple previous clinical trials involving incretin-based medications. These drugs work by mimicking natural hormones in the body that help control blood sugar and appetite. As a result, people feel less hungry and eat less, leading to weight loss.
The research team, led by Dr. John A. Batsis, found that while muscle loss is expected during any weight loss, the amount of muscle lost with these medications was higher than expected. In other words, a larger portion of the total weight lost came from muscle rather than fat.
This finding does not mean the medications are unsafe. They still provide clear benefits, especially for people with diabetes or severe obesity. However, it suggests that doctors and patients need to pay closer attention to what kind of weight is being lost.
Another important point raised by the study is the lack of research in older adults. Most clinical trials for these drugs include younger or middle-aged participants. Very few studies include people over the age of 60, and almost none focus specifically on those over 65.
This is important because older adults naturally lose muscle as they age. If a medication causes additional muscle loss, it could make this problem worse. That is why the researchers are calling for more studies that focus on aging populations and look at outcomes such as strength, mobility, and daily function.
The study also highlights the need for better monitoring. Instead of only tracking body weight, doctors may need to measure muscle mass and strength during treatment. This could help ensure that patients are losing fat in a healthy way while maintaining their physical abilities.
There are also ways to reduce muscle loss during weight loss. Regular physical activity, especially strength training, can help preserve muscle. Eating enough protein is also important, as protein supports muscle repair and growth.
In conclusion, this study provides an important reminder that weight loss is not just about the number on the scale. It is about overall health and body composition. While incretin-based medications remain powerful tools for treating obesity and diabetes, their effects on muscle should not be ignored.
Future research will be needed to better understand how to balance the benefits of these drugs with the need to protect muscle health. For now, patients and doctors should work together to ensure that weight loss is both effective and safe.
If you care about muscle, please read studies about factors that can cause muscle weakness in older people, and scientists find a way to reverse high blood sugar and muscle loss.
For more health information, please see recent studies about an easy, cheap way to maintain muscles, and results showing these vegetables essential for your muscle strength.
Source: University of North Carolina.
